Adding Eyelid Lesion Removal to Your Practice: The Business Case

Adding eyelid lesion removal to your practice is one of the highest-return, lowest-cost services an optometrist can offer. The lesions are ones you already diagnose every week, and the startup cost is a fraction of what a laser, scleral lens clinic, or dry eye suite demands. This guide lays out the business case: how much the service can add, what it costs to start, how billing works, and how it fits your existing exam without adding chair time.

Why eyelid lesion removal is a smart revenue stream?

Benign eyelid lesions are among the most common findings in a comprehensive exam. Squamous papilloma (skin tags), seborrheic keratosis, verruca, and xanthelasma walk through your door constantly, and historically most optometrists documented them and moved on, or referred them out. Every one of those referrals is practice revenue and goodwill leaving the building. When you can remove the lesion in the same chair where you found it, you convert a routine finding into a billable procedure and a patient who is grateful they did not need a second appointment somewhere else.

Patient demand is the part practices underestimate. Many patients have lived with a lid lesion for years, assuming removal meant surgery or a specialist. When you offer to handle it during the visit, a large share say yes on the spot. That is the rare service where clinical value, patient satisfaction, and practice economics all point the same direction.

How much can eyelid lesion removal add to your practice?

The per-case numbers are the reason this pencils out. Practices commonly report reimbursement in the range of $300 or more per lesion removal, and Review of Optometry reports many optometrists generating $350 or more per patient when treating benign lid lesions. Actual amounts vary by payer, region, technique, and the number of lesions treated, so treat these as directional rather than a fee schedule.

The math compounds with volume you already have. If you identify even a handful of candidates a week and a meaningful percentage accept, the service can add a substantial monthly line without a single new patient walking through the door. Because you are treating findings from exams you are already performing, the marginal acquisition cost is effectively zero.

The lowest-barrier specialty service to add

Compared with other ways to grow an optometry practice, lesion removal is remarkably light. Building a scleral lens clinic, integrating lasers, or standing up an advanced dry eye center each requires major capital, new rooms, or months of ramp-up. Chemical cautery, by contrast, is a low capital investment and causes very little disruption to clinic workflow. The core supplies are relatively inexpensive and shelf-stable, and unlike most surgical procedures, the technique is learnable in a focused training rather than a residency. Of all the minor procedures an optometrist can add, this has the lowest barrier to entry, which makes it the natural first step for a practice testing whether procedural care fits its model.

Cash pay or insurance? You have both lanes

Eyelid lesion removal can be billed to medical insurance when it is medically necessary and documented, or handled as cash pay when the patient wants a lesion removed for cosmetic reasons. That dual path is part of what makes it resilient. Medically necessary removals, where a lesion bleeds, irritates, obstructs vision, or shows worrisome change, are billed to the patient’s medical plan rather than a vision plan. Purely cosmetic removals are cash pay, and an Advance Beneficiary Notice sets that expectation in writing for Medicare patients. The CPT code most associated with chemical cautery of a benign lid lesion is 67850, while 67840 covers excision of an eyelid lesion; confirm the exact code, diagnosis, and any modifiers with your billing team, since payer rules vary. For the full picture, see our guide on eyelid lesion removal insurance coverage.

It keeps patients and revenue in-house

Referring a lesion out has a hidden cost beyond the lost procedure fee. The patient waits weeks, often pays more at an oculoplastics office, and sometimes never comes back to close the loop. Keeping the procedure in-house improves continuity of care and signals that your practice handles the full scope of periocular concerns.

It fits the exam you already run

The service integrates into existing workflow rather than requiring a separate surgical day. Treatments happen during the same visit in which the lesion is identified, which eliminates a referral, a second copay, and a scheduling gap. Chemical cautery in particular is fast, needs no injection, and can be done at the slit lamp, so it adds only a few minutes of chair time with no postoperative burden of sutures or heavy follow-up.

Recognized in Review of Optometry

The business case here is not just ours. Review of Optometry made it directly in the May 2026 article “Expand with Chemical Cautery” by Nate Lighthizer, OD, dean and chief of specialty care clinics at the NSU Oklahoma College of Optometry, which calls benign lid lesion removal one of the lowest-barrier ways to expand procedural care and cites the $350-per-patient figure. That article highlighted Derma Cautery by name as an optometrist-founded company providing ready-to-use in-office treatment kits along with in-person and online training built for optometrists, and noted that the training has received endorsement from the NSU Oklahoma College of Optometry. We were proud to be recognized as part of the optometrists-teaching-optometrists movement making these procedures accessible.

What you need to start offering lesion removal

Three things gate this service, and none of them are expensive. First, scope: confirm your state board permits the procedure, since privileges vary and began expanding with Oklahoma in 1998. Second, training and a protocol so you and your staff treat appropriate lesions confidently and recognize what to refer. Third, the materials themselves. The Derma Cautery training and treatment package bundles all three, pairing a standardized protocol and kit with coding and workflow guidance so a practice can add the service in weeks, not quarters. If you already diagnose these lesions every week, adding the ability to treat them is the shortest path to a new, high-margin service line.

What optometrists typically ask:

Is offering eyelid lesion removal profitable for an optometry practice?

For most practices, yes. Reimbursement commonly runs around $300 or more per case, the supplies are inexpensive, and you are treating findings from exams you already perform, so the added revenue carries very little marginal cost. Profitability still depends on your state scope, your payer mix, and how many candidates accept treatment.

How much does eyelid lesion removal reimburse?

Practices commonly report $300 or more per lesion removal, and Review of Optometry cites many optometrists generating $350 or more per patient for benign lid lesions. Amounts vary by payer, region, technique, and number of lesions, so confirm rates with your billing team rather than relying on a single figure.

What does it cost to start offering lesion removal?

Far less than most specialty services. Chemical cautery needs only inexpensive, shelf-stable supplies and focused training rather than new rooms or six-figure equipment, which is why it is considered the lowest-barrier minor procedure to add.

Can I bill insurance, or is it cash pay?

Both. Medically necessary removals are billed to the patient’s medical plan when documented, and purely cosmetic removals are cash pay, with an Advance Beneficiary Notice for Medicare patients. The dual path is part of what makes the service resilient.

Do I need special training to add lesion removal?

Yes, within your state scope, you need appropriate training, a defined protocol, and coding guidance. A structured system such as the Derma Cautery training and treatment package bundles the protocol, kit, and support so a practice can add the service confidently.

Will adding this disrupt my exam schedule?

Minimally. Chemical cautery is fast, needs no injection, and can be done at the slit lamp during the same visit the lesion is found, adding only a few minutes of chair time with no heavy follow-up.